Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection

Keyphrases

• Albendazole 100%
• Ivermectin 100%
• Thiabendazole 100%
• Strongyloides Stercoralis Infection 100%
• Confidence Interval 50%
• Risk Ratio 50%
• Adverse Events 33%
• Parasitological Cure 25%
• Strongyloides Hyperinfection Syndrome 16%
• Diarrhea 8%
• Infectious Diseases 8%
• Constipation 8%
• Chronic Infection 8%
• Immune Deficiency 8%
• Vomiting 8%
• Africa 8%
• Strongyloidiasis 8%
• Non-associated 8%
• Dizziness 8%
• Nausea 8%
• Serious Adverse Events 8%
• No-report 8%
• Search Methods 8%
• South-East Asia 8%
• MEDLINE 8%
• Embase 8%
• Randomized Controlled Trial 8%
• Cochrane 8%
• Cochrane Central Register of Controlled Trials 8%
• Disorientation 8%
• Respiratory Problems 8%
• Disease Groups 8%
• Skin Rash 8%
• Random Effects Model 8%
• Extracted Data 8%
• Drug Groups 8%
• Second Dose 8%
• Selection Criteria 8%
• Cochrane Library 8%
• Search Terms 8%
• Southeastern Europe 8%
• Strongyloides Stercoralis 8%
• Fixed Effects Model 8%
• Risk of Bias 8%
• Gut Infection 8%
• Event Definition 8%
• Benzimidazole 8%
• Event Risk 8%
• Adverse Event Data 8%
• Conference Abstracts 8%
• Review Authors 8%
• Common Worlds 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Albendazole 100%
• Ivermectin 100%
• Tiabendazole 100%
• Strongyloidiasis 100%
• Adverse Event 50%
• Infection 41%
• Strongyloides 16%
• Diarrhea 8%
• Constipation 8%
• Rash 8%
• Randomized Controlled Trial 8%
• Nausea 8%
• Dizziness 8%
• Immune Deficiency 8%
• Random Effects Model 8%
• Strongyloides stercoralis 8%
• Strongyloidea 8%
• Benzimidazole Derivative 8%
• Disorientation 8%

Medicine and Dentistry

• Strongyloidiasis 100%
• Albendazole 100%
• Ivermectin 100%
• Tiabendazole 100%
• Adverse Event 50%
• Infection 41%
• Strongyloides 16%
• Gut 8%
• Diarrhea 8%
• Constipation 8%
• Immune Deficiency 8%
• Exanthem 8%
• Randomized Controlled Trial 8%
• Nausea 8%
• Random Effects Model 8%
• Dizziness 8%
• Strongyloides stercoralis 8%
• Disorientation 8%
• Benzimidazole Derivative 8%